Effect of oral cyclosporin A in children with Staphylococcus aureus-colonized vs. S. aureus-infected severe atopic dermatitis

Pediatric Allergy and Immunology

Volumn 14, Issue 1, 2003, Pages 55-59

  Bunikowski, Rita ^a   Mielke, Martin ^b   Bräutigam, Matthias ^c   Renz, Harald ^d   Wahn, Ulrich ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c NOVARTIS PHARMA GMBH   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cyclosporin A; Reduction of Staphylococcal aureus density; Severe childhood atopic dermatitis; Staphylococcal exotoxins; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; BETAMETHASONE; CYCLOSPORIN A; STAPHYLOCOCCUS TOXIN;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL SKIN DISEASE; BACTERIUM CULTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; INFANT; MALE; PRIORITY JOURNAL; PRURITUS; PUS; PUSTULE; STAPHYLOCOCCUS AUREUS;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; CYCLOSPORINE; DERMATOLOGIC AGENTS; DRUG EVALUATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INCIDENCE; INFANT; INFANT WELFARE; MALE; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; STATISTICS; SUPERANTIGENS; TIME FACTORS; TREATMENT OUTCOME;

EID: 0037949002     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3038.2003.02105.x     Document Type: Article

References (18)

1. HERZ U, BUNIKOWSKI R, RENZ H. Role of T cells in atopic dermatitis. New aspect on the dynamics of cytokine production and the contribution of bacterial superantigens. Int Arch Immunol 1998: 115: 179-90.
2. LEYDEN JJ, MARPLES RR, KLIGMAN AM. Staphylococcus aureus in lesions of atopic dermatitis. Br J Dermatol 1974: 90: 525-30.
3. DAVID TJ, CAMBRIDGE GC. Bacterial infection and atopic eczema. Arch Dis Child 1986: 61: 20-3.
4. DRAKE CG, KOTZIN BL. Superantigens: Biology, immunology, and potential role in disease. J Clin Immunol 1992: 12: 149-62.
5. BUNIKOWSKI R, MIELKE EA, SKARABIS H, et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000: 105: 814-9.
6. LEVER R, HADLEY K, DOWNEY D, MACKIE R. Stapylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988: 119: 189-98.
7. NILSSON EJ, HENNING CG, MAGNUSSON J. Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 1992: 27: 29-34.
8. REMITZ A, KYLLONEN H, GRALUND H, REITAMO S. Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. J Allergy Clin Immunol 2001: 107: 196-7.
9. HARPER JI, AHMED I, BARCLAY G, et al. Cyclosporin for severe atopic dermatitis: short course versus continuous therapy. Br J Dermatol 2000: 142: 52-8.
10. BUNIKOWSKI R, STAAB D, KUSSEBI F, et al. Low dose cyclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediatr Allergy Immunol 2001: 12: 216-23.
11. EUROPEAN TASK FORCE ON ATOPIC DERMATITIS. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the Task Force of Atopic dermatitis. Dermatology 1993: 186: 23-31.
12. KUNZ B, ORANJE AP, LABREZE L, STALDER J-F, RING J, TAIEB A. Clinical Validation and guidelines for the SCORAD Index: Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1997: 195: 10-9.
13. DREYFUSS M, HÄRRI E, HOFMANN H, KOBEL H, PACHE W, TSCHARTER H. Cyclosporin A and C. European J Appl Microbiol 1976: 3: 125-33.
14. KUUSELA P, VARTIO T, VUENTO M. Binding sites for streptococci and staphylococci in fibronectin. Infect Immun 1984: 45: 433-6.
15. LOPES JD, REIS M, BRETANI RR. Presence of laminin receptors in Staphylococcus aureus. Science 1985: 229: 275-7.
16. BUNIKOWSKI R, GERHOLD K, BRÄUTIGAM M, HAMELMANN E, RENZ H, WAHN U. Effect of -dose Cyclosporin A microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. Int Arch Allergy Immunol 2001: 125: 344-8.
17. ZOLLNER TM, WICHELHAUS TA, HARTUNG A, et al. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 1999: 30: 994-1000.
18. DAVISON S, ALLEN M, VAUGHAN R, BARKER J. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigenreactive Vβ-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes. Clin Exp Immunol 2000: 121: 181-6.